Article info
PDFLetter
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines
- Correspondence to:
Professor RFA Logan, Division of Public Health and Epidemiology, School of Community Health Sciences, University of Nottingham Medical School, Nottingham NG7 2UH, UK;
Richard.Logan{at}nottingham.ac.uk
Citation
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines
Publication history
- First published September 11, 2003.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2003 by Gut